News & Events about Altimmune Inc.
Thinking about buying stock in Advanced Micro Devices, BigBear.ai, Riot Platforms, Bit Digital, or Altimmune? Thinking about buying stock in Advanced Micro Devices, BigBear.ai, Riot Platforms, Bit Digital, or Altimmune? PR Newswire NEW YORK, April 18, 2023 NEW YORK, April 18, 2023 /PRNewswire...
Thinking about buying stock in AMC Entertainment, Li Auto, Kingsoft Cloud, Altimmune, or Ford Motor? Thinking about buying stock in AMC Entertainment, Li Auto, Kingsoft Cloud, Altimmune, or Ford Motor? PR Newswire NEW YORK, April 17, 2023 NEW YORK, April 17, 2023 /PRNewswire...
Ticker Report
2 months ago
Altimmune (NASDAQ:ALT Get Rating)s stock had its market outperform rating restated by equities research analysts at JMP Securities in a research report issued on Wednesday, Benzinga reports. They currently have a $26.00 price objective on the stock. A number of other ...
Globe Newswire
4 months ago
Mr. Jordt brings over 25 years of industry experience in corporate strategy and business developmentGAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Raymond Jordt as Chief Business ...
Globe Newswire
4 months ago
GAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Chairman and Co-Founder, Pinnacle Clinical Research and Summit Clinical Research, will deliver an oral presentation of the ...